Retirement Planning Company of New England’s Pacira BioSciences PCRX Stock Holding History

Retirement Planning Company of New England’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,370	Closed	-$297K	–	231
2024 Q2	$297K	Buy	+10,370	New	+$295K	0.16%	157
2024 Q1	–	Sell	-6,280	Closed	-$212K	–	231
2023 Q4	$212K	Sell	6,280 -310	-5%	-$9.07K	0.1%	208
2023 Q3	$202K	Buy	6,590 +130	+2%	+$4.69K	0.11%	191
2023 Q2	$259K	Buy	6,460 +230	+4%	+$9.51K	0.15%	175
2023 Q1	$254K	Buy	6,230 +405	+7%	+$16.1K	0.15%	174
2022 Q4	$225K	Buy	5,825 +370	+7%	+$18K	0.15%	187
2022 Q3	$290K	Buy	+5,455	New	+$303K	0.21%	148
2022 Q1	–	Sell	-100	Closed	-$6K	–	687
2021 Q4	$6K	Buy	+100	New	+$5.51K	﹤0.01%	736

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Retirement Planning Company of New England's PCRX Position: Q3 2024 in Review

Retirement Planning Company of New England sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 10,370 shares — an estimated $297K sold.

Retirement Planning Company of New England first reported a position in PCRX in Q4 2021 and held it in 8 quarters. The position peaked at $297K in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

Retirement Planning Company of New England reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
Retirement Planning Company of New England sold 10,370 Pacira BioSciences shares in Q3 2024, an estimated $297K.
Retirement Planning Company of New England first reported a position in Pacira BioSciences in Q4 2021 and held it in 8 quarters.
Retirement Planning Company of New England's Pacira BioSciences position peaked at $297K in Q2 2024.
239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Retirement Planning Company of New England's 13F filing for Q3 2024, filed 12 Nov 2024.